17 results on '"LaBossiere J"'
Search Results
2. 21 The Canadian general surgery resident: defining current challenges for surgical leadership
- Author
-
Tomlinson, C., LaBossiere, J., Rommens, K., and Birch, D.W.
- Published
- 2011
3. Abstract 15536: Cardiopulmonary resuscitation with chest compressions during sustained inflations: A new technique of Neonatal Resuscitation that improves recovery and survival in a neonatal porcine model
- Author
-
Schmölzer, G.M., primary, O'Reilly, M., additional, LaBossiere, J., additional, Lee TF, T.F., additional, Cowan, S., additional, Qin, S., additional, Bigam, D.L., additional, and Cheung, P.H.Y., additional
- Published
- 2013
- Full Text
- View/download PDF
4. 317 The Cardio-Protective Effects of Doxycycline in a Swine Model of Neonatal Asphyxia
- Author
-
LaBossiere, J., primary, Pelletier, J., additional, Bigam, D., additional, and Cheung, P., additional
- Published
- 2012
- Full Text
- View/download PDF
5. 86 Low-Dose Vasopressin is Cardioprotective in an Acute Swine Model of Neonatal Hypoxia-Reoxygenation
- Author
-
Pelletier, J., primary, LaBossiere, J., additional, Gill, R., additional, Sergi, C., additional, Bigam, D., additional, Dicken, B., additional, and Cheung, P., additional
- Published
- 2012
- Full Text
- View/download PDF
6. 320 The Regional Hemodynamic Effects of Doxycycline in Newborn Piglets with Asphyxia-Reoxygenation
- Author
-
LaBossiere, J., primary, Pelletier, J., additional, Bigam, D., additional, and Cheung, P., additional
- Published
- 2012
- Full Text
- View/download PDF
7. Postfailure analysis: Tramping Lake causeway, Saskatchewan, Canada
- Author
-
Labossiere, J. L., primary, Sauer, E. K., additional, and Christiansen, E. A., additional
- Published
- 1989
- Full Text
- View/download PDF
8. 2024 Canadian Urological Association guideline: Female stress urinary incontinence.
- Author
-
Carlson K, Andrews M, Bascom A, Baverstock R, Campeau L, Dumoulin C, Labossiere J, Locke J, Nadeau G, and Welk B
- Published
- 2024
- Full Text
- View/download PDF
9. Complications after surgery for benign prostatic enlargement: a population-based cohort study in Ontario, Canada.
- Author
-
Matta R, Dvorani E, Wallis C, Hird A, LaBossiere J, Kulkarni G, Kodama R, Carr L, Radomski SB, Saskin R, Herschorn S, and Nam RK
- Subjects
- Aged, Aged, 80 and over, Databases, Factual, Humans, Linear Models, Male, Multivariate Analysis, Ontario, Preoperative Care adverse effects, Preoperative Care methods, Retrospective Studies, Time Factors, Adrenergic alpha-Antagonists adverse effects, Fibrinolytic Agents adverse effects, Postoperative Complications epidemiology, Prostatic Hyperplasia surgery
- Abstract
Objectives: To examine the complication rates after benign prostatic enlargement (BPE) surgery and the effects of age, comorbidity and preoperative medical therapy., Design: A retrospective, population-based cohort study using linked administrative data., Setting: Ontario, Canada., Participants: 52 162 men≥66 years undergoing first BPE surgery between 1 January 2003 to 31 December 2014., Intervention: Medical therapy preoperatively and surgery for BPE., Primary and Secondary Outcome Measures: The primary outcome was overall 30-day postoperative complication rates. Secondary outcomes included BPE-specific event rates (bleeding, infection, obstruction, trauma) and non-BPE specific event rates (cardiovascular, pulmonary, thromboembolic and renal). Multivariable analysis examined the association between preoperative medical therapy and postoperative complication rates., Results: The 30-day overall complication rate after BPE surgery was 2828 events/10 000 procedures and increased annually over the study period. Receipt of preoperative α-blocker monotherapy (relative rate (RR) 1.05; 95% CI 1.00 to 1.09; p=0.033) and antithrombotic medications (RR 1.27; 95% CI 1.22 to 1.31; p<0.0001) was associated with increased complication rates. Among the ≥80-year-old group, the rate of complications increased by 39% from 2003 to 2014 (RR 1.39; 95% CI 1.21 to 1.61; p<0.0001). The mean duration of medical and conservative management increased by a mean of 2.1 years between 2007 and 2014 (p<0.0001 for trend)., Conclusions: Thirty-day complication rates after BPE surgery have increased annually between 2003 and 2014. Preoperative medical therapy with alpha blockers or antithrombotics was independently associated with higher rates of complications. Over this time, the duration of conservative therapy also increased., Competing Interests: Competing interests: SH has received grants and personal fees from Astellas, Allergan, and Ipsen and personal fees from Pfizer and Duchesnay. SBR has acted as an advisory board member for Astellas, Pfizer, Merus, Allergan and participated in research for Astellas and Allergan. LC has participated in research and advisory board meetings for Cook MyoSite, and also serves on speakers boards for Astellas, Allergan, Pfizer, Duchesney USA and Ferring Pharmaceuticals., (© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
10. Exhaled CO2 Parameters as a Tool to Assess Ventilation-Perfusion Mismatching during Neonatal Resuscitation in a Swine Model of Neonatal Asphyxia.
- Author
-
Li ES, Cheung PY, O'Reilly M, LaBossiere J, Lee TF, Cowan S, Bigam DL, and Schmölzer GM
- Subjects
- Animals, Asphyxia Neonatorum physiopathology, Carbon Dioxide metabolism, Exhalation, Hemodynamics, Swine, Asphyxia Neonatorum therapy, Resuscitation methods, Ventilation-Perfusion Ratio
- Abstract
Background: End-tidal CO2 (ETCO2), partial pressure of exhaled CO2 (PECO2), and volume of expired CO2 (VCO2) can be continuously monitored non-invasively to reflect pulmonary ventilation and perfusion status. Although ETCO2 ≥14 mmHg has been shown to be associated with return of an adequate heart rate in neonatal resuscitation and quantifying the PECO2 has the potential to serve as an indicator of resuscitation quality, there is little information regarding capnometric measurement of PECO2 and ETCO2 in detecting return of spontaneous circulation (ROSC) and survivability in asphyxiated neonates receiving cardiopulmonary resuscitation (CPR)., Methods: Seventeen newborn piglets were anesthetized, intubated, instrumented, and exposed to 45-minute normocapnic hypoxia followed by apnea to induce asphyxia. Protocolized resuscitation was initiated when heart rate decreased to 25% of baseline. Respiratory and hemodynamic parameters including ETCO2, PECO2, VCO2, heart rate, cardiac output, and carotid artery flow were continuously measured and analyzed., Results: There were no differences in respiratory and hemodynamic parameters between surviving and non-surviving piglets prior to CPR. Surviving piglets had significantly higher ETCO2, PECO2, VCO2, cardiac index, and carotid artery flow values during CPR compared to non-surviving piglets., Conclusion: Surviving piglets had significantly better respiratory and hemodynamic parameters during resuscitation compared to non-surviving piglets. In addition to optimizing resuscitation efforts, capnometry can assist by predicting outcomes of newborns requiring chest compressions.
- Published
- 2016
- Full Text
- View/download PDF
11. 3:1 compression to ventilation ratio versus continuous chest compression with asynchronous ventilation in a porcine model of neonatal resuscitation.
- Author
-
Schmölzer GM, O'Reilly M, Labossiere J, Lee TF, Cowan S, Nicoll J, Bigam DL, and Cheung PY
- Subjects
- Animals, Animals, Newborn, Disease Models, Animal, Female, Heart Massage methods, Hemodynamics, Male, Random Allocation, Respiration, Artificial methods, Survival Rate, Swine, Asphyxia therapy, Cardiopulmonary Resuscitation methods, Heart Arrest therapy
- Abstract
Objective: In contrast to the resuscitation guidelines of children and adults, guidelines on neonatal resuscitation recommend synchronized 90 chest compressions with 30 manual inflations (3:1) per minute in newborn infants. The study aimed to determine if chest compression with asynchronous ventilation improves the recovery of bradycardic asphyxiated newborn piglets compared to 3:1 Compression:Ventilation cardiopulmonary resuscitation (CPR)., Intervention and Measurements: Term newborn piglets (n=8/group) were anesthetized, intubated, instrumented and exposed to 45-min normocapnic hypoxia followed by asphyxia. Protocolized resuscitation was initiated when heart rate decreased to 25% of baseline. Piglets were randomized to receive resuscitation with either 3:1 compressions to ventilations (3:1C:V CPR group) or chest compressions with asynchronous ventilations (CCaV) or sham. Continuous respiratory parameters (Respironics NM3(®)), cardiac output, mean systemic and pulmonary artery pressures, and regional blood flows were measured., Main Results: Piglets in 3:1C:V CPR and CCaV CPR groups had similar time to return of spontaneous circulation, survival rates, hemodynamic and respiratory parameters during CPR. The systemic and regional hemodynamic recovery in the subsequent 4h was similar in both groups and significantly lower compared to sham-operated piglets., Conclusion: Newborn piglets resuscitated by CCaV had similar return of spontaneous circulation, survival, and hemodynamic recovery compared to those piglets resuscitated by 3:1 Compression:Ventilation ratio., (Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
12. Cardiopulmonary resuscitation with chest compressions during sustained inflations: a new technique of neonatal resuscitation that improves recovery and survival in a neonatal porcine model.
- Author
-
Schmölzer GM, O'Reilly M, Labossiere J, Lee TF, Cowan S, Qin S, Bigam DL, and Cheung PY
- Subjects
- Animals, Animals, Newborn, Asphyxia physiopathology, Heart Arrest mortality, Heart Arrest physiopathology, Heart Arrest therapy, Insufflation methods, Random Allocation, Survival Rate trends, Swine, Time Factors, Asphyxia mortality, Asphyxia therapy, Cardiopulmonary Resuscitation methods, Chest Wall Oscillation methods, Disease Models, Animal, Recovery of Function physiology
- Abstract
Background: Guidelines on neonatal resuscitation recommend 90 chest compressions (CCs) and 30 manual inflations (3:1) per minute in newborns. The study aimed to determine whether CC s during sustained inflations (SIs) improves the recovery of asphyxiated newborn piglets in comparison with coordinated 3:1 resuscitation., Methods and Results: Term newborn piglets (n=8/group) were anesthetized, intubated, instrumented, and exposed to 45-minute normocapnic hypoxia followed by asphyxia. Piglets were randomly assigned to receive either 3:1 resuscitation (3:1 group) or CCs during SIs (SI group) when the heart rate decreased to 25% of baseline. Piglets randomly assigned to the SI group received SIs with a pressure of 30 cm H2O for 30 s. During the SI, CCs at a rate of 120/min were provided. SI was interrupted after 30 s for 1 s before a further 30-s SI was provided. CCs were continued throughout SIs. CCs and SI were continued until the return of spontaneous circulation. Continuous respiratory parameters, cardiac output, mean systemic and pulmonary artery pressures, and regional blood flows were measured. Mean (standard deviation) time for return of spontaneous circulation was significantly reduced in SI group versus 3:1 group (32 [11] s versus 205 [113] s, respectively). In the SI group, administration of oxygen and epinephrine was significantly lower, whereas minute ventilation and exhaled CO2 were significantly increased. The SI group had significantly higher mean systemic and pulmonary arterial pressures during resuscitation in comparison with the 3:1 group (51 [10] versus 31 [5] mm Hg; 41[7] versus 31 [7] mm Hg, respectively; all P<0.05), with improved cardiac output and carotid blood flow., Conclusions: Combining CCs and SIs significantly improved the return of spontaneous circulation with better hemodynamic recovery in asphyxiated newborn piglets in comparison with standard coordinated 3:1 resuscitation.
- Published
- 2013
- Full Text
- View/download PDF
13. Low-dose vasopressin improves cardiac function in newborn piglets with acute hypoxia-reoxygenation.
- Author
-
Pelletier JS, LaBossiere J, Dicken B, Gill RS, Sergi C, Tahbaz N, Bigam D, and Cheung PY
- Subjects
- Animals, Animals, Newborn, Asphyxia Neonatorum drug therapy, Dobutamine administration & dosage, Glutathione metabolism, Heart Ventricles metabolism, Hypoxia physiopathology, Lactic Acid metabolism, Lipid Peroxides blood, Mesenteric Artery, Superior, Oxygen blood, Reperfusion Injury drug therapy, Shock, Cardiogenic drug therapy, Swine, Troponin I blood, Cardiac Output drug effects, Hypoxia drug therapy, Reperfusion Injury physiopathology, Vasopressins administration & dosage
- Abstract
Cardiovascular dysfunction in asphyxiated neonates contributes significantly to their morbidity and mortality. We have recently shown that a low-dose vasopressin infusion (0.005 - 0.01 units/kg per hour) may improve myocardial oxygen transport balance in a swine model of neonatal hypoxia-reoxygenation. We aimed to compare the systemic and regional hemodynamic effects of low-dose vasopressin to dobutamine, a synthetic beta-adrenoreceptor agonist. Piglets (1 - 5 days old, 1.6 - 2.2 kg) were anesthetized and instrumented to continuously monitor systemic hemodynamic parameters, including cardiac output and mesenteric flow indices. After 2 h of hypoxia (10% - 15% O2), piglets had normoxic reoxygenation for 4 h. In a blinded randomized fashion, piglets received infusion of either vasopressin (0.01 units/kg per hour started at 30 min of reoxygenation) or dobutamine (20 μg/kg per minute started at 2 h of reoxygenation) (n = 8 per group). Hypoxia-reoxygenation controls (placebo, n = 8) and sham-operated (n = 5) piglets were also studied. Tissue lactate, glutathione, glutathione disulfide, and lipid hydroperoxides levels and histology of the left ventricle and the small bowel were analyzed. Plasma was also analyzed for troponin-I and intestinal fatty acid-binding protein levels. Piglets subjected to hypoxia-reoxygenation had cardiogenic shock and metabolic acidosis, which improved on reoxygenation. During recovery, cardiac output and mesenteric flows gradually deteriorated and were increased similarly in vasopressin- and dobutamine-treated piglets (P < 0.05 vs. controls). Plasma troponin-I and left ventricular lactate levels were lower in the vasopressin and dobutamine groups (P < 0.05 vs. controls), with no difference in the histological analysis among groups. The intestinal GSSG/GSH ratio and lipid hydroperoxides level were lower in the vasopressin and dobutamine groups (P < 0.05 vs. controls). This study is the first to demonstrate that a low-dose vasopressin infusion used in the setting of neonatal swine model of hypoxia-reoxygenation is associated with an improvement in cardiac output and mesenteric perfusion.
- Published
- 2013
- Full Text
- View/download PDF
14. Therapeutic strategies to protect the immature newborn myocardium during resuscitation following asphyxia.
- Author
-
Gill RS, Pelletier JS, LaBossiere J, Bigam DL, and Cheung PY
- Subjects
- Animals, Asphyxia drug therapy, Asphyxia therapy, Humans, Infant, Newborn, Reactive Oxygen Species metabolism, Resuscitation methods, Antioxidants pharmacology, Asphyxia metabolism, Heart drug effects, Heart physiopathology, Myocardium metabolism, Resuscitation adverse effects
- Abstract
Perinatal asphyxia contributes to over one million newborn deaths worldwide annually, and may progress to multiorgan failure. Cardiac dysfunction, of varying severity, is seen in 50%-70% of asphyxiated newborns. Resuscitation is necessary to restore oxygenation to deprived tissues, including the heart. However, reoxygenation of asphyxiated newborns may lead to generation of reactive oxygen species (ROS) and further myocardial damage, termed reperfusion injury. The newborn heart is especially vulnerable to oxidative stress and reperfusion injury due to immature antioxidant defense mechanisms and increased vulnerability to apoptosis. Currently, newborn myocardial protective strategies are aimed at reducing the generation of ROS through controlled reoxygenation, boosting antioxidant defenses, and attenuating cellular injury via mitochondrial stabilization.
- Published
- 2012
- Full Text
- View/download PDF
15. Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Society, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, London, Ont. Sept. 15-18, 2011.
- Author
-
Chiu JC, Shi X, Karmali S, Birch DW, Apriasz I, Alkhamesi NA, Lal A, Schlachta CM, Christou NV, Elkassem S, Lindsay D, Smith L, Sullivan P, Sockalingam S, Hawa R, Wnuk S, Jackson T, Okrainec A, Fayez R, Christou NV, Court O, Mueller C, Okrainec A, Sockalingham S, Jackson T, Mueller C, Swanson T, Daigle C, Okrainec A, Pitzul K, Penner T, Urbach DR, Jackson T, Sandhu L, Maciver A, McCall M, Edgar R, Thiesen A, Bigam D, Churchill T, Shapiro AMJ, Luu S, Regehr G, Murnaghan ML, Gallinger S, Moulton CA, Palter V, Grantcharov T, Dath D, Hoogenes J, Matsumoto E, Szalay D, Fox A, Pitzul K, Bhojani F, Kaplan M, Wei A, McGilvray I, Cleary SP, Okrainec A, Alqahtani A, Parsyan A, Payne R, Tabah R, Anantha R, Vogt K, Crawford S, Parry N, Leslie K, Ochs A, Matthew K, Khadaroo R, Churchill T, Lavoie JM, Zalai C, Vasilevsky CA, Booy J, Takata J, Tomlinson G, Urbach DR, Lim D, Tomlinson C, LaBossiere J, Rommens K, Birch DW, Brenneman F, MacLellan S, Simpson J, Asai K, Elgadi K, Ali S, Sawyer J, Helewa R, Turner D, Wirtzfeld D, Park J, Czaykowski P, Mak G, Hochman D, McKay A, Gill R, Al-Adra D, Shi X, Sample C, Armstrong J, Lester L, Vogt K, Brackstone M, Lee L, Kaneva P, Liberman S, Charlebois P, Stein B, Fried G, Feldman L, Kanji A, Sharon E, Asai K, Jacks L, McCready D, Ghazarian D, Leong WL, Wu R, Okrainec A, Penner T, Ball C, Kirkpatrick A, Vasquez A, Balakrishnan L, Miller G, Awan S, Azadeh NR, Hoogenes J, Dath D, Jain V, Busato GM, Cristea O, Landau J, Moreland R, Johnson M, Ramage D, Browning D, Ullah S, Cristea O, Bodrogi A, Johnson M, McAlister V, Palisoc J, Anderson J, Kiladze R, Ciar J, Bancel I, Pitzul K, Leake PA, Okrainec A, Dalvi A, McLean R, Stephen W, Loeb M, Smith R, Christoffersen E, Forbes S, Kidane B, Vogt K, Vinden C, Ahmadi N, Dubois L, McKenzie M, Baxter N, Brown C, Chaudhury P, Dixon E, Fitzgerald W, Henteleff H, Kirkpatrick A, Latosinsky S, MacLean A, McLeod R, Pearsall E, Aarts MA, Meghji Z, McLeod R, Okrainec A, Tran T, Kaneva P, Fried G, Mayo N, Feldman L, Newman D, Bergman S, Cummings BA, Delisle M, Whitehead V, Chertkow H, Chan T, Cicero M, Perampaladas K, Bandukwala T, Struble J, Moser M, Young P, Groeneveld A, Chan P, Smith S, Khadaroo R, Buczkowski A, Hameed M, Tan-Tam C, Meneghetti A, Simons R, Panton N, Elnahas A, Ghaderi I, Madani A, de Gara C, Schlachta CM, Kalechstein S, Pitzul K, Henao O, Okrainec A, Paskar D, Croome K, Hernandez R, Knapp G, Howatt N, Foster S, Cameron B, Austin J, Mack L, Temple W, Puloski S, Schachar N, Gill T, Doris P, Tecson A, Kolozsvari N, Andalib A, Kaneva P, Cao J, Vassiliou M, Fried G, Feldman L, Kolozsvari N, Kaneva P, Vassiliou M, Fried G, Feldman L, Kolozsvari N, Kaneva P, Brace C, Chartrand G, Vaillancourt M, Cao J, Banaszek D, Vassiliou M, Fried G, Feldman L, Fraser S, Bergman S, Deobald R, Chad J, Di Gregorio C, Johnstone J, Kenyon C, Lees M, Auger-Dufour E, Fried G, Feldman L, Ferri L, Vassiliou M, Alqahtani A, Perlman R, Holcroft C, Gordon PH, Szilagyi A, Iradukunda D, Moser MAJ, Rodych N, Shaw JM, Ahmed N, Chiu M, Kurabi B, Qureshi A, Nathens A, Conn LG, Pandya A, Kitto S, Ma G, Pooni A, Forbes S, Eskicioglu C, Pearsall E, Brenneman F, McLeod R, Rockx MA, McAlister V, Roberts D, Ouellet J, Kirkpatrick A, Lall R, Sutherland F, Ball C, Chackungal S, Knowlton LM, Dahn B, McQueen K, Morrison JA, Lent B, Brown J, Fluit M, Herbert C, Deen S, Deutschmann M, McFadden S, Gelfand G, Bosch D, Grimmer L, Milman S, Ng T, Gill R, Perry T, Abele J, Bedard E, Schiller D, Coughlin S, Stewart TC, Parry N, Gray D, Williamson J, Malthaner R, Bottoni D, Perri M, Trejos AL, Naish M, Patel R, Malthaner R, Ashrafi A, Bond J, Ong S, Yamashita M, Ahmadi S, Abdulmosen M, Miller J, Finley C, Ostrander K, Shargall Y, Lee L, Hanley S, Robineau C, Sirois C, Mulder D, Ferri L, Humphrey R, Inculet R, Fortin D, Arab A, Malthaner R, Ashrafi A, Bond J, Ong S, Yamashita M, Ahmadi S, McGuire A, Reid K, Petsikas D, Hopman W, Basi A, Basi S, Irshad K, Hanna W, Croome KP, Marotta P, McAlister V, Quan D, Wall W, Hernandez-Alejandro R, de Mestral C, Zagorski B, Rotstein O, Gomez D, Haas B, Laupacis A, Sharma S, Bridge J, Nathens A, Bhojani F, Fox A, Pitzul K, Moulton CA, Wei A, Okrainec A, Cleary S, Bertens K, Croome KP, Mujoomdar A, Peck D, Rankin R, Quan D, Kakani N, Hernandez-Alejandro R, Suri R, Marcaccio M, Ruo L, Jamal M, Khalil JA, Simoneau-Beaudry E, Dumitra S, Edwards M, Yousef Y, Jiffry MA, Metrakos P, Tchervenkov J, Doi S, Barkun J, Obayan A, Meiers S, Keith R, Elkassem S, Church N, Mitchell P, Turbide C, Dixon E, Debru E, Shum J, Wall WJ, Maniar R, Hochman D, Wirtzfeld D, Yaffe C, Yip B, McKay A, Silverman R, Park J, Francescutti V, Rivera L, Kane JM, Skitzki JJ, Lovrics P, Hodgson N, O'Brien MA, Thabane L, Cornacchi S, Heller B, Reid S, Sanders K, Kittmer T, Simunovic M, Duhaime S, Fong B, Deria M, Acton C, El-Maadawy M, Lad S, Arnaout A, Omole M, Pemberton J, Lovrics P, Bischof D, Stotland P, Hagen J, Swallow C, Klein L, Van Koughnett JA, Ahmad T, Ainsworth P, Brackstone M, Kanagaratnam S, Groot G, VanderBeek L, Francescutti V, Farrokhyar F, Strang B, Kahnamoui K, MacLellan S, MacKay H, Ringash J, Jacks L, Kassam Z, Khalili I, Conrad T, Okrainec A, Chagpar R, Xing Y, You N, Yi-Ju C, Feig B, Chang G, Cormie J, Gervais MK, Sideris L, Drolet P, Mitchell A, Leblanc G, Dubé P, Merchant S, Knowling M, Cheifetz R, Raval M, Heidary B, Kalikias S, Raval D, Phang T, Brown C, Scheer A, O'Connor A, Chan B, Moloo H, Poulin E, Mamazza J, Auer R, Boushey R, Hardy K, Vergis A, Sullivan P, Musselman R, Gomes T, Chan B, Auer R, Moloo H, Poulin E, Mamazza J, Al-Khayal K, Al-Omran M, Mamdani M, AlObeed O, Boushey R, Martel G, Crawford A, Barkun J, Ramsay C, Fergusson D, Boushey R, Williams L, Crawford A, McLaughlin K, Mackey M, Moloo H, Mamazza J, Poulin E, Friedlich M, Boushey R, Auer R, Bellolio F, Cohen Z, MacRae H, O'Connor B, Huang H, Victor JC, McLeod R, Hardy K, Pitzul K, Kwong J, Vergis A, Urbach D, Okrainec A, Vogt K, Dubois L, Vinden C, Chan B, Scheer A, Menezes A, Moloo H, Poulin E, Boushey R, Mamazza J, Bellolio F, MacRae H, Cohen Z, O'Connor B, Huang H, McLeod R, Godbout-Simard C, Azar J, Psaradellis F, Sampalis J, Morin N, Brown C, Kalikias S, Heidary B, Raval D, Phang PT, Raval M, Archibald A, Hurlbut D, Vanner S, Zalai C, Vasilevsky CA, Simunovic M, Cadeddu M, Forbes S, Kelly S, Stephen W, Grubac V, Marcinow M, Coates A, Aslani N, Phang PT, Raval M, Brown C, Scheer A, Carrier M, Boushey R, Asmis T, Wells P, Jonker D, Auer R, Azer N, Gill R, de Gara C, Birch DW, Karmali S, Roxin G, Drolet S, MacLean A, Buie WD, Heine J, Agzarian J, Forbes S, Stephen W, Kelly S, Churchill P, Corner T, Kelly S, Forbes S, Lindsay L, Stephen W, Scheer A, O'Connor A, Chan B, Moloo H, Poulin E, Mamazza J, Auer R, Boushey R, Denis J, Hochman D, Recsky M, Phang PT, Raval M, Cheung W, Brown C, Alkhamesi N, Schlachta CM, Tiwari T, Brown C, Raval MJ, and Phang PT
- Published
- 2011
16. Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease.
- Author
-
Cheung J, Yu A, LaBossiere J, Zhu Q, and Fedorak RN
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Outcome Assessment, Health Care, Recurrence, Renal Dialysis, Retrospective Studies, Risk Factors, Kidney Failure, Chronic complications, Peptic Ulcer Hemorrhage complications
- Abstract
Background: Patients with end-stage renal disease (ESRD) and peptic ulcer disease (PUD) bleeding may be at high risk of bleeding complications., Objective: To investigate the outcomes of patients with ESRD and PUD bleeding., Design: ESRD patients with PUD bleeding were evaluated retrospectively., Setting: Two tertiary, university-affiliated hospitals., Patients: A total of 150 PUD bleeding patients were evaluated in 3 groups; end-stage renal disease (ESRD) patients on dialysis (ESRD group) (n = 50) were age matched with patients with chronic kidney disease (CKD) not requiring dialysis (CKD group) (n = 50) and those with normal kidney function (normal group) (n = 50)., Main Outcome Measurements: Rebleeding, transfusions, length of hospitalization, mortality., Results: Multivariate analysis showed significant predictors of rebleeding to be ESRD and high-risk stigmata. The ESRD group had an odds ratio (OR) of 3.8 (95% CI, 1.4-10.5; P = .008) for rebleeding compared with the normal group, and an OR of 3.8 (95% CI, 1.4-10.3; P = .01) compared with the CKD group. The mean number of (+/- SD) transfusions was higher in the ESRD group (6.3 +/- 5.7 units) than in the normal group (3.6 +/- 3.9 units; P = .01). The mean length of hospitalization was higher in the ESRD group than in the normal group (34.0 vs 16.6 days; P = .01). A greater level of comorbidity was the only significant predictor of mortality (OR 6.0; 95% CI, 2.9-12.3; P = .001)., Limitation: Retrospective study., Conclusion: ESRD dialysis patients with PUD bleeding have greater rebleeding than patients not on dialysis. ESRD patients should be managed as a high-risk group., (2010 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
17. Arrhythmias in the PACU. A review.
- Author
-
Tremblay DR, Fischer RL, Caouette CJ, Graves GA, and Labossiere JH
- Subjects
- Arrhythmias, Cardiac diagnosis, Arrhythmias, Cardiac etiology, Electrocardiography, Humans, Postoperative Complications diagnosis, Postoperative Complications etiology, Arrhythmias, Cardiac therapy, Postoperative Complications therapy, Recovery Room
- Abstract
The patient emerging from anesthesia has been subjected to a myriad of predisposing causes of dysrhythmias. Adequate pain control; relief of anxiety; maintenance of proper ventilation and oxygenation; prompt treatment of hypothermia; accurate assessment of vital signs, electrolytes, hemoglobin, and hematocrit; observation for signs of hemorrhage; and continuous cardiac monitoring should be afforded every PACU patient. When dysrhythmias occur, prompt recognition, evaluation of possible causes, and appropriate interventions should be instituted.
- Published
- 1991
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.